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Highlights 
 Nesfatin-1 potentiated mucosal gastric vagal afferent responses to mucosal 
stroking in lean mice fed ad libitum or fasted overnight, an effect not observed in 
high fat diet mice. 
 Gastric vagal tension receptor mechanosensitivity was unaffected by nesfatin-1 in 
lean mice fed ad libitum or fasted overnight, but was inhibited in high fat diet mice. 
 Plasma concentrations of nesfatin-1were unchanged between standard laboratory 
diet mice fed ad libitum or fasted overnight and high fat diet fed mice. 
 The precursor for nesfatin-1 (NUCB2 mRNA) was detected in the gastric mucosa 
and gonadal fat with no difference in expression between fed ad libitum, fasted and 
high fat diet fed groups. 
 Nesfatin-1 modulated gastric vagal afferents in a nutritional state dependent 
manner. 
 
Abstract 
Food intake is regulated by vagal afferent signals from the stomach. Nesfatin-1 is an 
anorexigenic peptide produced within the gastrointestinal tract and has well defined central 
effects. We aimed to determine if nesfatin-1 can modulate gastric vagal afferent signals in the 
periphery and further whether this is altered in different nutritional states. Female C57BL/6J 
mice were fed either a standard laboratory diet (SLD) or a high fat diet (HFD) for 12 weeks or 
fasted overnight. Plasma nucleobindin-2 (NUCB2; nesfatin-1 precursor)/nesfatin-1 levels were 
assayed, the expression of NUCB2 in the gastric mucosa and adipose tissue was assessed 
using real-time quantitative reverse-transcription polymerase chain reaction. An in vitro 
preparation was used to determine the effect of nesfatin-1 on gastric vagal afferent 
mechanosensitivity. HFD mice exhibited an increased body weight and adiposity. Plasma 
NUCB2/nesfatin-1 levels were unchanged between any of the groups of mice. NUCB2 mRNA 
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was detected in the gastric mucosa and gonadal fat of SLD, HFD and fasted mice with no 
difference in mRNA abundance between groups in either tissue. In SLD and fasted mice 
nesfatin-1 potentiated mucosal receptor mechanosensitivity, an effect not observed in HFD 
mice. Tension receptor mechanosensitivity was unaffected by nesfatin-1 in SLD and fasted 
mice, but was inhibited in HFD mice. In conclusion, Nesfatin-1 modulates gastric vagal afferent 
mechanosensitivity in a nutritional state dependent manner.  
 
Abbreviations: CCK, cholecystokinin; HFD, high fat diet; 5-HT, 5-hydroxytryptamine; 
NUCB2, nucleobindin-2; QRT-PCR, real-time quantitative reverse-transcription polymerase 
chain reaction; SLD, standard laboratory diet;  
 
Keywords 
Nesfatin-1, obesity, vagal afferents  
 
 
1. Introduction 
Gastric vagal afferents are a vital peripheral mechanism by which the gastrointestinal tract can 
communicate with the CNS to modulate food intake as well as gastrointestinal function. Within 
the stomach of mice there are two populations of mechanosensitive vagal afferent [33]. These 
can be discriminated based on their responses to mechanical stimuli [33]. The first are tension 
sensitive afferents which have a well characterized role, detecting distension and contraction 
of the stomach wall, and can activate satiety circuitry in the brain [52]. The second class are 
mucosal afferents and whilst they are well defined morphologically and electrophysiologically, 
their role in modulating physiological function is less clear [2-4]. Limited evidence suggest a 
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role for these afferents in detecting food particle size within the lumen to provide negative 
feedback on the control of gastric emptying [1]. 
 
The gastrointestinal tract is littered with discrete cell populations which contain peptides and 
other chemicals which have the ability to modulate vagal afferent firing and also regulate food 
intake [10]. These peptides include classic mediators of food intake such as leptin [23], ghrelin 
[21], 5-hydroxytryptamine (5-HT), cholecystokinin (CCK) [11, 42] and adiponectin [25]. In 
addition, there are substantial amounts of nesfatin-1 located within discrete vesicles in X/A-
like cells within the stomach [48]. These specialised X/A-like endocrine cells also produce the 
orexigenic peptide ghrelin [48]. 
 
The nesfatin-1 peptide is a relatively recent discovery. It was originally identified as a 
hypothalamic satiety factor being present in the paraventricular nucleus where it has been 
shown to reduce food intake in a melanocortin 3/4 receptor dependent and leptin independent 
manner [32]. Nesfatin-1 has also been shown to potentiate the excitatory and inhibitory effect 
of glucose on sub-populations of glucose sensing neurons in the dorsal vagal complex [13]. 
In addition, it is present in neurons of the nucleus tractus solitaries activated by gastric 
distension [6]. Nesfatin-1 has also been shown to activate isolated CCK and capsaicin 
sensitive vagal afferent neurons by increasing Ca2+ influx [18]. Additionally, peripheral 
administration of the active fragment of nesfatin-1 fails to reduce food intake in mice that have 
been treated with capsaicin [46]. Together this evidence suggests a possible vagal route of 
action for nesfatin-1 to regulate food intake. However, to date, there have been no studies to 
establish the effect of nesfatin-1 on gastric vagal afferent endings and whether this may 
represent a peripheral mechanism by which nesfatin-1 could modulate food intake. 
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Peptidergic signalling is known to be sensitive to nutritional status and nesfatin-1 is no 
exception. Gastric nucleobindin 2 (NUCB2, precursor for nesfatin-1) content has been shown 
to be decreased in fasting [48]. Diet induced obesity is also associated with altered levels of 
appetite regulating peptides including leptin, ghrelin, peptide YY [49] and NUCB2/nesfatin-1 
[31]. Furthermore, expression of receptors for gut peptides is altered in the cell bodies of vagal 
afferents within the nodose ganglia in fasted and diet induced obese rats and mice [34]. 
Gastric vagal afferent mechanosensitivity responses to peptides are also altered in obesity. 
For example, the effect of leptin on gastric vagal afferents switches from potentiation of 
mucosal receptors to an inhibition of tension receptors in obesity [24]. Thus, it needs to be 
determined whether the effects of nesfatin-1 on vagal afferent function depend on nutritional 
status. 
 
Through the use of in vitro electrophysiology we sought to identify the effect of nesfatin-1 on 
gastric vagal afferent mechanosensitivity in lean, obese and fasted mice to determine a 
possible role in the modulation of gastric vagal afferent mediated physiological functions under 
different states of nutrition.  
2. Materials and Methods 
2.1 Ethical approval 
All experimental protocols were approved by the animal ethics committees of the Institute of 
Medical and Veterinary Science, South Australian Health and Medical Research Institute 
(SAHMRI) and the University of Adelaide and were conducted in accordance with the 
Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. 
 
2.2 Mouse study groups 
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Thirty 7 week old female C57BL/6J mice (Animal Resource Centre, Perth, Australia) were 
acclimatized for 1 week before being randomly divided into two groups and fed either a high 
fat diet (HFD, N=18) comprising 60%, 20%, 20% of energy from fat, protein, and carbohydrate 
(Adapted from Research Diets Inc., New Brunswick, USA) or a standard laboratory diet (SLD, 
N=12) comprising 12%, 23%, 65% of energy from fat, protein and carbohydrate (Specialty 
Feeds, Glen Forest, Western Australia) respectively for 12 weeks.  A maximum of four mice 
were housed per cage and were kept under 12 hour light: dark cycles with ad libitum access 
to food and water. A separate group of age matched female mice (N=6), fed a SLD for 12 
weeks at the same time and under identical conditions to the other two groups, were fasted 
overnight prior to experimentation. 
 
2.3 In vitro mouse gastric vagal afferent preparation 
After the completion of the 12 week diet period mice fed ad libitum or fasted overnight were 
euthanized between 0600 and 0900hr, via 4% isoflurane anaesthetic and exsanguination 
through the abdominal aorta followed by decapitation. The stomach and oesophagus including 
both vagal nerves were dissected as previously described [21]. In short, the stomach and 
oesophagus, with intact vagal nerves, were removed. The stomach and oesophagus were 
opened out longitudinally mid-way between the two main vagal branches, either side of the 
oesophagus, and along the greater curvature of the stomach. The ventral half of the stomach 
was removed and kept for the real-time quantitative reverse-transcription polymerase chain 
reaction (QRT-PCR) experiments described below. The dissection process was carried out at 
4°C in modified Krebs solution composing of (in mM): 118.1 NaCl, 4.7 KCl, 25.1 NaHCO3, 1.3 
NaH2PO4, 1.2 MgSO4.7H2O, 1.5 CaCl2, 1.0 citric acid, 11.1 glucose and 0.001 nifidipine, 
bubbled with 95% O2- 5% CO2. The tissue was then pinned down mucosa side up in a purpose 
built organ bath and superfused with the oxygenated modified Krebs solution. The vagal 
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afferent nerves were passed through into an adjacent paraffin oil filled chamber for 
electrophysiology recording. 
 
2.3.1 Characterization of gastric vagal afferent properties 
The location of individual receptive fields corresponding to afferent fibres was identified by 
mechanical stimulation of the mucosa with a soft brush. The sub-type of each afferent was 
then further determined by responses specific to each sub-type of gastric vagal afferent 
mechanoreceptor, as previously described [21]. Since the mucosal gastric vagal afferent 
receptive field is generally very small (≈1mm2), the response of the middle 8 of 10 stimulations 
was averaged to minimize error. For tension receptors, circular tension was applied by a hook, 
placed adjacent to the receptive field, attached to a cantilever via suture silk. Weights were 
applied in a step-wise manner from 1-5g for 1min per weight and the response measured as 
mean discharge frequency over the 1min period. A recovery period of 1min was allowed 
between the applications of each tension stimuli. 
 
2.3.2 Effect of nesfatin-1 on the mechanosensitivity of gastric vagal afferents 
Following the establishment of gastric vagal afferent baseline mechanosensitivity, the effect 
of nesfatin-1 on the mechanosensitivity was determined. Nesfatin-1 (30pM), at a concentration 
previously reported in the literature [9], was added to the modified Krebs, superfused into the 
organ bath and allowed to equilibrate for 20min to ensure penetration of all layers of the gastric 
tissue before vagal afferent mechanosensitivity was re-determined. This procedure was 
repeated for higher doses of nesfatin-1 (100 and 300pM). Time control experiments were 
utilized to ensure that no significant change in mechanosensitivity occurred over a comparable 
duration independent of addition of nesfatin-1. 
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2.4 Quantification of plasma NUCB2/nesfatin-1 
Plasma samples extracted from the blood collected from the abdominal aorta during 
euthanasia, between 0600 and 0900hr, were analysed in duplicate for circulating 
NUCB2/nesfatin-1 levels using a Phoenix Peptides Nesfatin-1 (1-82) (rat) ELISA kit (EK-003-
22)[31] as per the manufacturer’s instructions (Phoenix Peptides, Burlingame, CA, USA) using 
the same assay kit. Quantification was measured at 450nm. The NUCB2/nesfatin-1 assay has 
a detection threshold of 1.26ng mL-1, with a detectable range from 0.1-1000 ng mL-1. The 
amount of immunoreactive material was determined using a non-linear regression curve-fit. 
This was used to quantify and compare the concentration of NUCB2/nesfatin-1 in the plasma 
samples.  Plasma concentrations of NUCB2/nesfatin-1 were not obtained for all of the mice 
studied due to the fact that an insufficient quantity of plasma was collected from some mice.  
 
2.5 Real-time quantitative reverse-transcription polymerase chain reaction (QRT-PCR) 
During the dissection, for the in vitro gastric vagal afferent preparation, the gastric mucosa 
was removed from the unused ventral half of the stomach by gently scrapping the mucosa 
from the muscular layers using a scalpel blade. The gastric mucosa was snap frozen in liquid 
nitrogen and stored at -80°C until required. Total RNA was then extracted from the mucosa 
using a PureLink® RNA Mini Kit (12183018A, Ambion (Thermo Fisher, Scoresby, VIC, 
Australia). The gonadal fat pads were also collected during the dissection for the in vitro gastric 
vagal afferent preparation. They were weighed and snap frozen in liquid nitrogen prior to 
storage at -80°C. RNA was extracted from the fat using a TRIzol® Plus RNA Purification Kit 
(12183555, Ambion (Thermo Fisher)), in accordance with the manufacturer's instructions. The 
RNA yield and quality were quantified on a NanoDrop™ Lite spectrophotometer (Thermo 
Fisher) with an OD260/280 in the range of 1.8 – 2.0 accepted as sufficiently pure for downstream 
applications. 
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For evaluation of NUCB2 expression, in stomach mucosa and white adipose tissue from SLD, 
HFD and fasted mice, QRT-PCR reactions were performed as previously described [28], using 
a 7500 Fast Real-time PCR System (Applied Biosystems® (Thermo Fisher)) and analysed 
with DataAssistTM Real-Time PCR Analysis Software (Applied Biosystems®). Samples were 
converted to cDNA using SuperScript® III First-Strand Synthesis SuperMix (18080400, 
Invitrogen (Thermo Fisher)). Quantification reactions were performed in triplicate according to 
the manufacturer's specifications with a TaqMan® Fast Advanced Master Mix (4444964, 
Applied Biosystems (Thermo Fisher)), incorporating specific pre-made TaqMan® gene 
expression assays (Applied Biosystems (Thermo Fisher)) for the detection of NUCB2 
(Mm01137144_m1),  β-actin (Actb; Mm00607939_s1), hypoxanthine guanine phosphoribosyl 
transferase (Hprt; Mm00446968_m1), β-2 microglobulin (B2m; Mm00437762_m1), 18S 
ribosomal (Rn18s; Mm03928990_g1) and peptidylprolyl isomerase A (Ppia; 
Mm02342429_g1) mRNA. Five housekeepers were tested for stability in stomach scrapings 
and fat from SLD, HFD and fasted mice. Normfinder stability values [35] indicate (Table 1) that 
Ppia, Hprt and B2m were appropriate stable housekeepers for stomach scraping samples, 
whereas, Ppia, actb and B2m were more appropriate for adipose tissue.  Relative mRNA 
transcript expression was calculated as previously described [37] and normalised to  the 
housekeepers Ppia, Hprt and B2m for stomach scrapings and Ppia, Actb and B2m for adipose 
tissue. No template controls for each gene expression assay were also performed. 
 
2.6 Drugs 
Nesfatin-1 (1μM; SRP4914, Sigma-Aldrich, Castle Hill, NSW, Australia) was kept frozen (-
80°C) and used freshly diluted for each experiment. 
 
2.7 Statistical analysis 
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All data in graphs are expressed as mean ± SEM with N= the number of individual animals 
used. Vagal afferent stimulus-response curves and weight change were analysed using two-
way analysis of variance (two-way ANOVA) and Sidak post hoc tests. The effect of nutritional 
state on the modulatory action of nesfatin-1 on responses to mechanical stimulation was 
determined by assessing the response to either stroking (200mg von Frey hair, mucosal 
receptors) or tension (3g, tension receptors) at the different concentrations of nesfatin-1 (30-
300pM). Significant difference in the effects of nesfatin-1 between the different fed states was 
assessed using two-way ANOVA with Sidak’s post-hoc test. NUCB2 mRNA levels and plasma 
NUCB2/nesfatin-1 levels were analysed using a one-way ANOVA with Tukey’s post-hoc test. 
Fat mass and final body weight was assessed using unpaired t-tests. Significance was defined 
at P<0.05. 
 
3. Results 
3.1 Effect of long-term alterations in diet on body composition 
Mice on the HFD gained 54.94 ± 8.13% of their initial weight which was significantly more than 
the 25.88 ± 1.73% gained by the SLD mice (Fig. 1A, P<0.001 vs SLD, two-way ANOVA, Sidak 
post hoc test) causing them to be significantly heavier at the end of the 12 week diet period 
(SLD: 22.65±0.50g, HFD: 29.06±1.73g, Fig. 1B, P<0.01, unpaired t-test). The HFD mice also 
had increased gonadal adiposity of 1.29±0.24g compared to the SLD mice with 0.22±0.07g 
(Fig. 1C, P<0.01, unpaired t-test). The stomach content at the point of tissue collection was 
significantly greater in the SLD (0.2256±0.03g (n=12)) and HFD (0.1761±0.03g (n=18)) ad 
libitum fed mice compared to the mice fasted overnight (0.0356±0.01g (n=6); data not shown, 
P<0.01, one-way ANOVA, Tukey post-hoc test). There was no significant difference in 
stomach content between SLD and HFD ad libitum fed mice. Plasma NUCB2/nesfatin-1 was 
similar in SLD (6.11±0.37ng mL-1), HFD (5.53±0.31ng mL-1) and fasted (5.64±0.59ng mL-1) 
mice (Fig. 1D, P>0.05, one-way ANOVA, Tukey post-hoc test). 
11 
 
 
3.2 NUCB2 expression in gastric mucosa and gonadal fat 
QRT-PCR was used to determine the expression of NUCB2 in the gastric mucosa (Fig 2A) 
and gonadal white adipose tissue (Fig. 2B). There were no significant differences in the 
abundance of NUCB2 mRNA detected between any of the mouse groups (P>0.05, one-way 
ANOVA). 
 
3.3 Effect of long-term alterations in diet on gastric vagal afferent response to nesfatin-
1 
3.3.1 Mucosal Receptors 
In SLD mice nesfatin-1 dose-dependently potentiated the response of mucosal receptors to 
mucosal stroking with calibrated von Frey hairs (Fig 3A, 10-1000mg, P<0.05, two-way 
ANOVA, nesfatin-1 effect). In animals that had been fasted overnight nesfatin-1 still 
potentiated mucosal receptor mechanosensitivity (Fig 3B, 30pM: P<0.05, 100pM: P<0.001, 
300pM: P<0.01, two-way ANOVA, nesfatin-1 effect). In mice that had been fed the HFD for 12 
weeks (Fig. 3C) nesfatin-1 had no effect on mucosal receptor mechanosensitivity (P>0.05, 
two-way ANOVA, nesfatin-1 effect). When the percentage increase in the response to mucosal 
stroking with a 200mg von Frey hair was plotted against the concentration of nesfatin-1 for 
both SLD and fasted mice nesfatin-1 had a significant potentiating effect on mucosal receptor 
mechanosensitivity (Fig. 3D, both P<0.01 vs. HFD, two-way ANOVA, nutritional status effect) 
compared to the HFD mice where there was no effect of nesfatin-1. There was no significant 
difference between the nesfatin-1 induce potentiation observed in the SLD mice and the fasted 
mice (P>0.05, two-way ANOVA, nutritional state effect). 
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3.3.2 Tension Receptors 
In the SLD (Fig. 4A) and fasted mice (Fig. 4B) nesfatin-1 had no effect on tension receptor 
mechanosensitivity (both P>0.05, two-way ANOVA, nesfatin-1 effect). However, nesfatin-1   
significantly reduced the response of gastric tension receptors to mechanical stretch in mice 
fed the HFD for 12 weeks (Fig. 4C; P<0.05 vs. control, two-way ANOVA, nesfatin-1 effect). 
Analysis of the percentage inhibition of the response to 3g stretch caused by each 
concentration of nesfatin-1 in the three groups of mice revealed a significant gain in the 
inhibitory effect of nesfatin-1 on tension receptors in HFD fed mice (Fig 4D, P<0.05 vs SLD, 
two-way ANOVA, nutritional state effect), an effect absent in both the SLD and fasted mice. 
 
4. Discussion 
We demonstrate that nesfatin-1 has the ability to potentiate the mechanosensitivity of mucosal 
gastric vagal afferents in lean animals and that this ability is lost in HFD induced obesity and 
fasting. In addition, nesfatin-1 inhibited tension receptor mechanosensitivity in HFD mice. 
 
In the current study we demonstrate that chronic HFD feeding for 12 weeks had no effect on 
gastric NUCB2 mRNA expression. In contrast, it has been demonstrated that feeding mice a 
HFD, identical to the diet used in the current study, for a longer period of time (17 weeks) 
caused a reduction in gastric NUCB2 mRNA levels [31]. However acute HFD feeding, in vivo, 
had no effect on gastric NUCB2 expression [31]. It is possible that the reduction in NUCB2 
mRNA expression is only apparent after extensive exposure to a HFD, longer than the 12 
weeks of the current study. The reduction in NUCB2 mRNA expression could be specific to 
the type of fatty acid that is consumed because it has previously been demonstrated that 
treatment with oleic acid, but not octanoic or linolenic acid, caused a reduction in NUCB2 
mRNA expression in cell lines (MGN3-1 cells) [31]. The HFD used in both the current study 
and the study by Mohan et al. utilised lard as the fat source which contains a dominant amount 
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of oleic acid. Therefore the reduction in gastric NUCB2 expression observed after 17 weeks 
could be due to chronic exposure to oleic acid.    
 
Adipose tissue nesfatin-1 protein levels have been shown to be increased in HFD fed mice 
and reduced in fasted mice [41]. Our results indicate a potential for increased NUCB2 mRNA 
in the gonadal adipose tissue which would be consistent with these results. However, there 
was considerable variation in NUCB2 between samples which prevented statistical 
significance from being reached. Plasma nesfatin-1 has previously been shown to be 
decreased in HFD mice [8]. We observed no change in plasma NUCB2/nesfatin-1 levels in 
mice fed a HFD or food restricted compared to mice fed a SLD. This discrepancy could be 
due to differences in diet duration (4 weeks in [8]) as well as potential sex differences in the 
regulation of nesfatin-1 levels which have previously been reported [16]. In addition, in the 
current study HFD mice were fed ad libitum, whereas, in the previous report [8], the decrease 
in plasma nesfatin concentration, in HFD mice, was observed in mice fasted for 6 hours [8]. 
Therefore the different feeding states could also explain the discrepancy. In humans there is 
similar controversy with some studies reporting a  positive linear correlation [41, 50], others 
reporting no correlation [17, 30], and another study reporting a negative correlation [51] 
between BMI and plasma NUCB2/nesfatin-1.  
 
Potentiation of mucosal receptor mechanosensitivity by nesfatin-1 may represent a peripheral 
mechanism by which nesfatin-1 can influence food intake. Whilst there is no direct evidence 
for gastric mucosal receptors in the control of food intake, their activation may lead to delayed 
gastric emptying, which can indirectly regulate food intake. Centrally administered nesfatin-1 
has been shown to delay gastric emptying [47]. In addition, release of nesfatin-1 from 
adipocytes has been shown to be triggered by increasing glucose levels [15]. Increased 
glycaemia leads to delayed gastric emptying [44]. Thus, it is possible that after the ingestion 
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of a meal, increased circulating glucose may trigger the release of nesfatin-1 from adipocytes 
and perhaps gastric X/A cells, which could act locally to reduce gastric emptying, retaining 
food in the stomach longer. This hypothesis is highly speculative and requires further 
investigation. 
 
A nesfatin-vagal pathway for the regulation of food intake is controversial. In rats, 
intracerebroventricular administration of nesfatin-1 (0.3-0.9nmol/rat) causes a reduction in 
food intake [39]. In contrast, peripheral administration of nesfatin-1 (8-73nmol/Kg) has been 
shown to have no effect on food intake despite being administered at doses 30 times higher 
than the intracerebroventricular administered nesfatin-1 [39]. In mice, there have been mixed 
reports for a peripheral effect of nesfatin-1 on food intake with one study showing no effect 
[14] and another showing a dose-dependent decrease in food intake [45] after intraperitoneal 
administration of nesfatin-1. The strongest evidence for vagal involvement in the anorexigenic 
effect of nesfatin-1 has been shown in a study with mice pretreated with capsaicin [46]. 
Capsaicin treatment caused the loss of capsaicin sensitive neurons [27],                     which 
have been shown to be activated by nesfatin-1 in vitro [19]. The capsaicin treatment prevented 
the reduction in food intake in response to nesfatin-1 administration [46]. This suggests that 
at least part of the anorexigenic effects of nesfatin is vagally mediated. However, whilst 
capsaicin treatment was originally believed to be an afferent lesioning tool there is now 
evidence to suggest efferent nerves are also affected [7]. Therefore the lack of effect of 
nesfatin-1 on food intake after capsaicin application could be due to altered sensory function 
or as a consequence of disrupted efferent function. Given the crude nature of this approach it 
remains to be conclusively determined whether the vagal afferents constitute an important 
route for nesfatin-1 to reduce food intake. Nonetheless, given the relative abundance of 
nesfatin-1 in the stomach (about 10 fold higher than the brain [48]) it would be logical for the 
vagus to be involved in the actions of nesfatin-1, similar to the action of other gastric peptides 
such as leptin [36] and ghrelin [12]. 
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Our finding that nesfatin-1 inhibits tension receptor mechanosensitivity in HFD-induced obese 
mice suggests that in an obese state nesfatin-1 may increase food intake through the delaying 
of gastric satiety signals. However, this is doubtful as nesfatin-1 has been shown to reduce 
food intake in both leptin receptor deficient obese mice and HFD mice [45]. Additionally, 
intracerebroventricular administration of nesfatin-1 reduces food intake in both lean and obese 
rats [39]. Furthermore, nesfatin-1 reduced food intake through a reduction in meal size in lean 
rats whereas it increased inter-meal duration and reduced meal frequency in obese rats [39]. 
This suggests that diet induced obesity is associated with discrete changes in the anorexigenic 
effect of nesfatin-1. Tension receptors are involved in regulating acute food intake through the 
restriction of meal size. Thus, it is possible that whilst nesfatin-1 has a net anorexigenic effect 
in obese animals it may still influence meal size by inhibiting tension receptor 
mechanosensitivity. This is just speculation and the physiological significance of the nesfatin-
vagal pathway needs to be addressed through further experiments. It is important to note that 
gastrointestinal vagal afferents are implicated in the regulation of numerous other functions. 
Therefore it remains a distinct possibility that the altered gastric vagal afferent response to 
nesfatin-1 may have no importance in the regulation of food intake, but instead be involved in 
the regulation of other vagally mediated functions within the gastrointestinal tract. For 
example, gastrointestinal peptides, via vagally mediated mechanisms, have been 
demonstrated to regulate gastric motility as well as gastrointestinal and pancreatic secretions 
[20, 29, 43]. In addition, alterations in vagal tone can impact on inflammation, respiration and 
heart rate [5, 38, 40] in response to a meal. 
Gastric vagal afferent mechanosensitivity exhibits a circadian rhythmicity that is completely 
abolished in HFD induced obesity [22, 26]. The plasma levels of NUCB2/nesfatin-1 also 
appear to vary throughout the day [31]. In the current study, experiments were only performed 
within a short time range (0600-0900hr) to eliminate variation in mechanosensitivity due to this 
observed circadian rhythmicity. However, it has been demonstrated that the appetite hormone 
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leptin potentiates gastric mucosal receptor mechanosensitivity in a time of day dependent 
manner [26].  Therefore, it is possible that the effect of nesfatin-1 on gastric vagal afferent 
mechanosensitivity also varies throughout the day. This requires further investigation. 
5. Conclusion 
In conclusion, we show that the ability for nesfatin-1 to modulate gastric vagal afferent 
mechanosensitivity is sensitive to both over nutrition and deprivation. It still remains to be 
determined what the functional importance of this is in terms of regulation of food intake. 
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Figure legends 
 
Figure 1: High fat diet feeding increases mouse weight and adiposity. (A) Proportional 
body weight gain over the 12 week diet period for mice that had either been fed a standard 
diet (SLD, ○) or a high fat diet (HFD, □). (B) Final body weight, (C) gonadal fat mass and (D) 
plasma nesfatin-1 levels in mice that were fed either SLD or HFD for 12 weeks or fasted 
overnight. (A) *P<0.05, ***P<0.001 vs. SLD, two-way ANOVA, Sidak post-hoc test. (B) and 
(C) ** P<0.01 vs. SLD, unpaired t-test (D) one-way ANOVA, P>0.05. 
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Figure 2: Nucleobindin 2 expression in the gastric mucosa and fat. The relative 
abundance of nucleobindin 2 mRNA present in the (A) gastric mucosa and (B) gonadal white 
adipose tissue in mice that were fed either the SLD (open bars), HFD (closed bars) or fasted 
overnight (checked bars). 
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Figure 3: Nesfatin-1 potentiated gastric mucosal receptor mechanosensitivity in 
standard laboratory diet (SLD) fed and fasted mice. The responses of gastric mucosal 
receptors to mucosal stroking with calibrated von Frey hairs (10–1000mg) in the absence (○
) and presence of nesfatin-1 30pM (□), 100pM (Δ) and 300pM (◊) from mice (A) fed a SLD, 
(B) fasted overnight  or (C) fed a high fat diet (HFD). *P< 0.05, **P<0.01, ***P<0.001 vs. ○, 
two-way ANOVA, nesfatin-1 effect. (D) Diet significantly affected the potentiating action of 
nesfatin-1 on the response of mucosal receptors to mucosal stroking with a 200mg von Frey 
hair (**P<0.01, vs. HFD, two-way ANOVA, nutritional state effect). 
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Figure 4: Nesfatin-1 gains an inhibitory effect on tension receptor mechanosensitivity 
in high fat diet (HFD) fed mice. The responses of gastric tension receptors to circular stretch 
with calibrated weights (1–5g) in the absence (○) and presence of nesfatin-1 30pM (□), 
100pM (Δ) and 300pM (◊) from mice (A) fed a standard laboratory diet (SLD), (B) fasted 
overnight or (C) fed a HFD. *P< 0.05, vs. ○, two-way ANOVA, nesfatin-1 effect. (D) Diet 
significantly affected the inhibitory action of nesfatin-1 to the response to 3g stretch (D; 
*P<0.05, vs. SLD, two-way ANOVA, nutritional state effect). 
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Table Legend 
Table 1: Expression stability values of the candidate housekeeper genes β-actin (Actb), 
hypoxanthine guanine phosphoribosyl transferase (Hprt), β-2 microglobulin (B2m), 18S 
ribosomal (Rn18s) and peptidylprolyl isomerase A (Ppia) calculated using the Normfinder 
algorithm.*The lower the value the more stable the housekeeper gene. 
 Rank Gene NormFinder stability 
value* 
Stomach scrapings 1 Hprt 0.012 
2 Ppia 0.032 
3 B2m 0.042 
4 Actb 0.057 
5 Rn18s 0.131 
White adipose tissue 1 Ppia 0.017 
2 Actb 0.039 
3 B2m 0.077 
4 Hprt 0.088 
5 Rn18s 0.097 
 
 
